China Food and Drug Administration Approves ORTHO VISION® Platform for Transfusion Medicine Labs
RARITAN, N.J. and SHANGHAI, Oct. 25, 2017 /PRNewswire/ -- Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, today announced that its ORTHO VISION(®) Platform of fully automated blood analyzers for low-, mid- and high-volume transfusion medicine laboratories has received approval by the China Food and Drug Administration (CFDA). The platform is now commercially available in China. ORTHO VISION and ORTHO VISION Max are now commercially available in various countries around the world, including the U.S. and in Europe.
The ORTHO VISION Platform is comprised of analyzers that test blood for compatibility, ensuring transfusion patients receive the right blood. The ORTHO VISION Max was developed for mid- to high-volume labs, and it also supports more complex immunohematology testing, such as serial dilutions for titration studies, reflex tests and selected cell antibody identification. The ORTHO VISION was developed for mid-volume labs.
"Around the world, transfusion medicine labs are facing increasing pressure to perform more tests with fewer resources, and yet their work in ensuring that all patients receive safe and appropriate blood remains critically important," said Robert Yates, chief operating officer, Ortho Clinical Diagnostics. "Ortho is committed to helping labs become more efficient while continuing to perform precise, accurate testing."
The ORTHO VISION Platform is designed to manage unpredictable workflow. It allows the transfusion medicine department to process routine samples and STAT orders as they are received, rather than waiting for a complete batch before running the instrument.
"Ortho is already a leader in transfusion medicine in China," said Michael Lin, head of Ortho China. "Because it is flexible and highly scalable, ORTHO VISION will help us continue to meet the rapidly evolving needs of our customers."
The platform has received a string of accolades for its ability to innovate in transfusion medicine. Earlier this year, the ORTHO VISION Platform was recognized with an Edison(TM) Award for Innovation. It also received a 2016 Innovation Award by members of Premier, Inc., a health care improvement company that unites an alliance of approximately 3,600 U.S. hospitals and 120,000 other providers around the goal of transforming health care, and a Global Business Excellence 2017 Award for Product Innovation.
About the ORTHO VISION Platform
Developed in direct partnership with transfusion medicine specialists, the ORTHO VISION Platform offers a comprehensive suite of products for both individual and multi-site health network hospitals. Producing reliable and consistent results, the ORTHO VISION Platform can be trusted by lab professionals to monitor and efficiently manage curves and shifts in workflow without needing adjustment.
With an instrument that automates more tests than ever before(i), technicians can spend less time on the bench and optimize their skills to focus on other critical tasks.
About Ortho Clinical Diagnostics
Ortho Clinical Diagnostics is a global leader of in vitro diagnostics serving the global clinical laboratory and immunohematology communities. Across hospitals, hospital networks, blood banks and labs in more than 125 countries and territories, Ortho's high-quality products and services enable health care professionals to make better-informed treatment decisions. For the immunohematology community, Ortho's blood typing products help ensure every patient receives blood that is safe, the right type and the right unit. Ortho brings sophisticated testing technologies, automation, information management and interpretation tools to clinical laboratories around the world, helping them run more efficiently and effectively, and improve patient care. Ortho's purpose is to improve and save lives with diagnostics, and it does that by reimagining what's possible. This is what has defined Ortho for more than 75 years, and it's what drives Ortho forward. For more information, visit www.orthoclinicaldiagnostics.com.
ORTHO VISION and ORTHO VISION Max are trademarks of Ortho Clinical Diagnostics.
© Ortho Clinical Diagnostics 2017
(i) Ortho Clinical Diagnostics Technical Data Sheets on File
View original content with multimedia:http://www.prnewswire.com/news-releases/china-food-and-drug-administration-approves-ortho-vision-platform-for-transfusion-medicine-labs-300542471.html
SOURCE Ortho Clinical Diagnostics
